With so many companies developing vaccines for the coronavirus the media is a frenzy with information, but what does any of it mean? We talked in the past about the development of the vaccine and started to get a sense of what might be different as far as information with the Russian development. Join hosts Shanti and Danny as we bring back special guest Dr. Bryan Simons to discuss what may be the most important episode of this podcast to date. A real-time analysis of the research conducted in Russia, the data that’s been released, and what it truly means.
Logunov, D., et. al.; Safety and Immunogenicity of an rAd26 and rAd5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine in Two Formulations: Two Open, Non-randomised Phase ½ Studies from Russia. The Lancet. 04-Sep-2020. Doi: https://doi.org/10.1016/S0140-6736(20)31866-3
Bucci, E.; Note of Concern: Open Letter to DY Logunov et. al.,. Cattivi Scienziati. 07-Sep-2020. https://cattiviscienziati.com/2020/09/07/note-of-concern/
Parodi, E.; Scientists from 5 Countries Question Accuracy of Russia Coronavirus Vaccine Data.15-Sep-2020. Global News Canada. https://globalnews.ca/news/7335548/russia-coronavirus-vaccine-lancet/